Read about rhabdomyosarcoma diagnosis stories and the latest in rhabdomyosarcoma research.
(American Association for Cancer Research) – Among children with intermediate-risk rhabdomyosarcoma (RMS) that is negative for a fusion gene, those who had a high score of a specific gene signature called MG5 had poorer survival outcomes compared with those who […]
7 Months Old at Diagnosis Knox was as happy as ever. There was no indication that the 7-month-old boy might be sick other than the bump his mother, Alexa, found while changing his diaper. Alexa took Knox to the family’s
Knox Thomas Lewis, Alveolar Rhabdomyosarcoma Read More »
New CureSearch Young Investigator Ranjit Bindra is studying novel targeted drugs for alveolar rhabdomyosarcoma (ARMS). His research promises to stimulate further drug discovery with the ultimate goal of delivering new medications that can be used to treat ARMS and other rare cancers.
Dr. Ranjit Bindra, Young Investigator: Rhabdomyosarcoma Read More »
Jason Yustein, MD, PhD, is a CureSearch Young Investigator studying rhabdomyosarcoma at Baylor College of Medicine. Dr. Yustein’s research focuses on creating new models of mice that spontaneously develop rhabdomyosarcoma (RMS), which are useful because they allow researchers to analyze the genetics and molecular pathways altered in RMS development and progression.
Researcher Studies Gene Pathways Responsible for Metastatic Rhabdomyosarcoma Read More »
